Evidence map›Paper›PMID 36615231›Full record

ArticleMolecules (Basel, Switzerland)2022

Biological Activity of Amidino-Substituted Imidazo [4,5-

Ida Boček Pavlinac, Katarina Zlatić, Leentje Persoons, Dirk Daelemans, Mihajlo Banjanac, Vedrana Radovanović, Kristina Butković, Marijeta Kralj, Marijana Hranjec

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ida Boček PavlinacFaculty of Chemical Engineering and Technology, University of Zagreb, 10000 Zagreb, Croatia.
Katarina ZlatićDivision of Molecular Medicine, Institute Ruđer Bošković, 10000 Zagreb, Croatia.ORCID 0000-0002-1375-1677
Leentje PersoonsKU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, 3000 Leuven, Belgium.ORCID 0000-0002-7898-0868
Dirk DaelemansKU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, 3000 Leuven, Belgium.ORCID 0000-0001-7092-1153
Mihajlo BanjanacPharmacology In Vitro, Selvita Ltd., 10000 Zagreb, Croatia.
Vedrana RadovanovićPharmacology In Vitro, Selvita Ltd., 10000 Zagreb, Croatia.
Kristina ButkovićChemistry, Selvita Ltd., 10000 Zagreb, Croatia.
Marijeta KraljDivision of Molecular Medicine, Institute Ruđer Bošković, 10000 Zagreb, Croatia.ORCID 0000-0002-7165-2722
Marijana HranjecFaculty of Chemical Engineering and Technology, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0002-3994-0054
Rega Institute for Medical Research · BERuđer Bošković Institute · HRUniversity of Zagreb · HR

Funding

Croatian Science Foundation 4379
6 · The paper itself

Abstract

A series of cyano- and amidino-substituted imidazo[4,5-

Indexed as

Antineoplastic AgentsPyridinesAnti-Bacterial AgentsCell Line, TumorCell ProliferationEscherichia coliHumansStructure-Activity RelationshipAnti-Bacterial AgentsAntineoplastic AgentsPyridinesamidinesantibacterial activityantiproliferative activityantiviral activityimidazo[4,5-b]pyridines

Identifiers

PMID36615231
PMCPMC9822021
OpenAlexW4313468789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.